This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Cardiac murmurs and other cardiac sounds
R18_CARDIAC_MURMU_OTHER_CARDIAC_SOUNDS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
4365 |
4. Check minimum number of eventsNone |
4365 |
5. Include endpointsNone |
4365 |
6. Filter based on genotype QC (FinnGen only) |
4365 |
Control definitions (FinnGen only)
- Control exclude
- R18_SYMPTOMS_SIGNS_INVOLVI_CIRCULATO_RESPI_SYSTEMS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R0
- Name in latin
- Murmura cardiaca et alii soni cardiaci
Similar endpoints
↥List of similar endpoints to
Cardiac murmurs and other cardiac sounds
based on the number of shared cases.
Similar with more cases:
- Symptoms and signs involving the circulatory and respiratory systems
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4365 | 2949 | 1416 |
| Unadjusted period prevalence (%) | 0.88 | 1.01 | 0.62 |
| Median age at first event (years) | 43.66 | 42.37 | 46.35 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3870
- Matched controls
- 38255
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R01.0
ICD-10 Finland
Benign and innocent cardiac murmurs
2252.6
323.0
2737
39
R01.1
ICD-10 Finland
Cardiac murmur, unspecified
99.0
323.0
1266
187
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
5.4
323.0
1147
2750
R07.4
ICD-10 Finland
Chest pain, unspecified
5.5
196.3
647
1356
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
5.5
155.8
506
1026
R06.0
ICD-10 Finland
Dyspnoea
4.3
152.9
636
1673
R01.2
ICD-10 Finland
Other cardiac sounds
511.8
151.0
150
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.7
135.9
670
2035
R06.5
ICD-10 Finland
Mouth breathing
10.0
84.2
174
179
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
74.5
1267
7466
R06.2
ICD-10 Finland
Wheezing
11.2
67.2
130
118
I35.0
ICD-10 Finland
Aortic (valve) stenosis
4.8
65.4
230
496
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.5
48.3
417
1765
R04.0
ICD-10 Finland
Epistaxis
6.0
48.1
137
231
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
47.0
805
4614
XF402
NOMESCO Finland
ECG with work load test
3.2
45.9
253
809
XF640
NOMESCO Finland
NA
6.6
44.3
117
179
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
41.5
666
3709
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
39.3
504
2563
R04.2
ICD-10 Finland
Haemoptysis
17.7
38.1
60
34
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
38.0
1392
9930
R05
ICD-10 Finland
Cough
2.1
37.4
498
2570
R00.2
ICD-10 Finland
Palpitations
3.5
36.2
178
521
R07.3
ICD-10 Finland
Other chest pain
3.5
36.2
178
521
R03AC02
ATC
salbutamol; inhalant
1.5
35.5
1655
12463
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.1
30.3
379
1898
C08CA01
ATC
amlodipine; oral
1.7
30.3
809
5245
R01
ICD-10 Finland
Cardiac murmurs and other cardiac sounds
51.3
30.2
36
7
UJF32
NOMESCO Finland
Coloscopy
1.7
29.6
656
4024
G47.3
ICD-10 Finland
Sleep apnoea
1.9
27.9
422
2275
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.1
27.8
160
528
C07AB07
ATC
bisoprolol; oral
1.5
27.2
1026
7236
SPAT1263
SPAT
Sampling
1.5
27.0
1484
11366
N03AX12
ATC
gabapentin; oral
1.9
26.2
386
2059
C03CA01
ATC
furosemide; systemic
1.7
26.0
569
3468
J45.1
ICD-10 Finland
Nonallergic asthma
2.5
26.0
217
898
R03DC03
ATC
montelukast; oral
1.8
25.2
476
2766
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
24.1
1094
8000
I34.1
ICD-10 Finland
Mitral (valve) prolapse
4.2
24.0
93
223
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
23.9
529
3229
SPAT1153
SPAT
Removal of sutures
1.5
23.4
893
6278
SPAT1097
SPAT
Recording of ECG
1.9
23.3
366
1995
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.1
23.2
285
1411
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
23.0
1395
10787
XFE00
NOMESCO Finland
Epicardial ultrasonography
4.4
22.7
84
193
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
22.7
356
1941
A02BC02
ATC
pantoprazole; systemic
1.4
22.4
1709
13774
N02BE01
ATC
paracetamol; systemic, rectal
1.4
21.8
2733
24013
XF404
NOMESCO Finland
Ambulatory ECG
2.3
21.3
211
952
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
3.2
20.8
110
343
R00.0
ICD-10 Finland
Tachycardia, unspecified
3.9
20.6
86
222
AA1AD
NOMESCO Finland
CT of head and brain
1.6
20.4
548
3516
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
20.2
209
960
C09CA01
ATC
losartan; oral
1.6
20.1
536
3434
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.7
20.0
427
2567
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
19.9
815
5788
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.1
19.8
245
1215
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
19.7
1433
11370
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
19.6
1616
13092
1201
NOMESCO Finland
NA
198.6
19.5
20
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.6
19.4
147
577
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.5
19.4
159
650
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
19.4
1137
8672
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
19.3
409
2454
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
19.2
426
2590
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.3
19.2
100
309
SPAT1312
SPAT
General health counselling
1.4
19.2
1288
10057
R42
ICD-10 Finland
Dizziness and giddiness
1.6
19.2
516
3314
SPAT1301
SPAT
No procedures
1.4
18.9
1048
7896
C10AA05
ATC
atorvastatin; oral
1.5
18.7
793
5661
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
18.5
268
1416
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
18.2
407
2481
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
18.1
417
2560
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.9
18.1
263
1391
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
18.0
1311
10359
R03BA02
ATC
budesonide; inhalant
1.6
17.9
471
3000
R06.4
ICD-10 Finland
Hyperventilation
11.8
17.6
32
27
A11
ICPC
Chest pain NOS
2.3
17.6
160
693
J01CA04
ATC
amoxicillin; systemic
1.4
17.5
3036
27550
C08CA13
ATC
lercanidipine; oral
1.9
17.5
285
1568
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
17.5
206
1005
S18
ICPC
Laceration/cut
1.4
17.4
1200
9383
R00.1
ICD-10 Finland
Bradycardia, unspecified
7.1
17.3
42
59
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
17.3
2507
22046
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
17.2
134
536
M79.6
ICD-10 Finland
Pain in limb
1.4
17.2
968
7294
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
17.1
343
2022
R02
ICPC
Shortness of breath/dyspnoea
1.8
16.6
290
1637
M25.5
ICD-10 Finland
Pain in joint
1.4
16.1
782
5722
SPAT1325
SPAT
Vaccination
1.4
16.1
1209
9560
C01DA14
ATC
isosorbide mononitrate; oral
2.0
15.9
209
1065
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
15.8
115
445
R03BA05
ATC
fluticasone; inhalant
1.5
15.7
523
3529
XG410
NOMESCO Finland
Flow-volume spirometry
2.8
15.5
97
343
R03BA01
ATC
beclometasone; inhalant
1.7
15.4
323
1932
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.9
15.3
239
1300
C10AA01
ATC
simvastatin; oral
1.4
15.2
896
6788
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
3.6
15.1
67
185
A10AE04
ATC
insulin glargine; parenteral
1.9
15.0
221
1177
C09AA05
ATC
ramipril; oral
1.5
15.0
477
3185
N02AX02
ATC
tramadol; systemic, rectal
1.4
15.0
972
7482
J01DB01
ATC
cefalexin; oral
1.3
14.9
2738
24624
H02AB06
ATC
prednisolone; systemic
1.3
14.9
1200
9565
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
14.8
315
1891
L17
ICPC
Foot/toe symptom/complaint
1.4
14.7
770
5699
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
14.7
427
2787
R09.1
ICD-10 Finland
Pleurisy
5.8
14.6
41
71
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
18.2
14.6
22
12
R60.0
ICD-10 Finland
Localized oedema
1.8
14.5
243
1351
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
14.4
1114
8813
M54.6
ICD-10 Finland
Pain in thoracic spine
2.1
14.4
174
857
B01AC04
ATC
clopidogrel; oral
1.8
14.1
259
1488
SPAT1310
SPAT
Counselling related to known health issue
1.3
14.0
1093
8646
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
14.0
2476
22016
J45
ICD-10 Finland
Asthma
1.8
14.0
248
1404
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.3
14.0
69
207
N03AX16
ATC
pregabalin; oral
1.5
13.9
514
3547
C10AX09
ATC
ezetimibe; oral
1.9
13.9
200
1057
J01FF01
ATC
clindamycin; systemic
1.4
13.9
677
4941
C10AA07
ATC
rosuvastatin; oral
1.5
13.8
499
3425
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
13.8
1849
15815
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
13.8
786
5900
SPAT1262
SPAT
Handing over of treatment supplies
1.6
13.8
424
2803
AN1
HP
Coronary angiography
2.0
13.8
167
824
R03AC03
ATC
terbutaline; inhalant
1.6
13.7
353
2233
A02BC05
ATC
esomeprazole; systemic
1.4
13.7
937
7260
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
13.6
196
1037
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
13.6
336
2105
R51.80
ICD-10 Finland
Headache
1.5
13.5
437
2927
M54.5
ICD-10 Finland
Low back pain
1.4
13.4
850
6494
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
13.1
1128
9046
R52.9
ICD-10 Finland
Pain, unspecified
1.8
13.1
218
1214
C02AC05
ATC
moxonidine; oral
2.6
13.1
95
369
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
13.0
595
4281
B01AA03
ATC
warfarin; systemic
1.6
13.0
345
2201
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
13.0
512
3577
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
12.9
879
6793
A46
ICD-10 Finland
Erysipelas
1.7
12.7
285
1738
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
12.6
382
2514
N06AX11
ATC
mirtazapine; oral
1.4
12.6
799
6098
J01FA09
ATC
clarithromycin; systemic
1.3
12.5
920
7191
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.6
12.4
89
342
R01AD09
ATC
mometasone; nasal
1.3
12.3
1293
10645
WX892
NOMESCO Finland
Monitored bed care
1.9
12.3
177
937
R96
ICPC
Asthma
1.8
12.3
211
1187
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
12.3
502
3534
G44.2
ICD-10 Finland
Tension-type headache
1.6
12.2
342
2210
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.4
12.0
97
398
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
11.9
323
2071
R07.2
ICD-10 Finland
Precordial pain
5.9
11.8
32
54
R07.0
ICD-10 Finland
Pain in throat
1.9
11.7
164
860
R50.9
ICD-10 Finland
Fever, unspecified
1.5
11.6
416
2851
R03BA08
ATC
ciclesonide; inhalant
1.9
11.5
166
879
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
11.4
626
4656
WX872
NOMESCO Finland
Intensive care
2.4
11.4
99
422
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
11.4
1665
14268
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.5
11.3
90
367
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.8
11.3
183
1010
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
11.3
438
3043
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
11.3
151
779
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
11.3
1716
14769
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
2.3
11.3
101
437
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
11.2
176
958
A02BC01
ATC
omeprazole; systemic
1.4
11.2
633
4727
FME20
NOMESCO Finland
Transvenous aortic valve replacement via femoral artery
5.5
11.2
32
58
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.6
11.1
324
2115
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
11.1
197
1119
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.4
11.0
91
379
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
11.0
259
1601
R06AE07
ATC
cetirizine; oral
1.3
11.0
1349
11296
K02.1
ICD-10 Finland
Caries of dentine
1.3
10.9
1942
17013
H02AB04
ATC
methylprednisolone; systemic
1.5
10.8
325
2137
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
10.7
331
2190
A98
ICPC
Health maint/preventive medicine
1.6
10.7
3674
35213
R53
ICD-10 Finland
Malaise and fatigue
1.4
10.7
511
3702
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
10.7
377
2569
M48.0
ICD-10 Finland
Spinal stenosis
1.7
10.7
221
1316
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.4
10.6
50
147
C07AB02
ATC
metoprolol; systemic
1.5
10.6
389
2676
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
10.6
256
1592
Q21.10
ICD-10 Finland
Persistent ostium secundum
3.7
10.6
45
122
FN1AD
NOMESCO Finland
CT of coronary arteries
6.6
10.5
26
39
WX110
NOMESCO Finland
Local anesthesy
1.3
10.5
2349
21096
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.0
10.4
127
632
205
Kela drug reimbursment
Chronic hypertension
1.4
10.4
542
3991
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
10.4
500
3626
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.6
10.4
75
293
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
10.4
225
1362
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
10.3
236
1448
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
10.3
1787
15561
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
10.3
456
3258
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.6
10.3
296
1926
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.3
10.2
50
152
K30
ICD-10 Finland
Functional dyspepsia
1.7
10.2
228
1388
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
10.2
1505
12855
I49.3
ICD-10 Finland
Ventricular premature depolarization
2.0
10.2
132
674
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
10.2
298
1946
C09CA07
ATC
telmisartan; oral
1.9
10.2
144
760
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
10.1
214
1285
L03
ICPC
Low back symptom/complaint
1.4
10.1
658
5028
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.8
10.0
177
1006
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.6
10.0
269
1719
R01AD12
ATC
fluticasone furoate; nasal
1.3
10.0
879
7020
WX408
NOMESCO Finland
General anesthesy, balanced
1.3
9.9
735
5725
SPAT1210
SPAT
Application of cast or individual aid
2.0
9.9
125
629
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.9
9.9
146
783
A02BC03
ATC
lansoprazole; oral
1.4
9.9
601
4538
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
9.9
518
3816
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
9.9
275
1776
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.8
9.8
153
834
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
9.8
419
2971
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
9.8
943
7621
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
9.8
463
3346
SPAT1254
SPAT
Administration of medicine
1.4
9.8
519
3830
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
9.7
169
956
UJD02
NOMESCO Finland
Gastroscopy
2.1
9.7
101
471
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.9
9.6
57
198
A29
ICPC
General symptom/complaint other
1.5
9.6
284
1863
R03AK08
ATC
formoterol and beclometasone; inhalant
2.5
9.6
72
287
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
9.5
98
457
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
9.4
187
1102
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
2.0
9.4
117
589
SBA00
NOMESCO Finland
Microbiological examinations
2.4
9.4
75
310
J01DA01
ATC
[U] cefalexin; systemic
1.2
9.2
1807
15883
I49.1
ICD-10 Finland
Atrial premature depolarization
2.5
9.2
69
274
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
4.1
9.1
34
83
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
9.1
1428
12239
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
9.0
985
8081
SPAT1260
SPAT
Consultation of another employee
1.4
9.0
498
3699
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
9.0
183
1087
B01AB05
ATC
enoxaparin; parenteral
1.3
9.0
678
5288
C08CA05
ATC
nifedipine; systemic
1.9
8.9
124
651
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.8
8.9
163
937
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
8.9
378
2675
WX720
NOMESCO Finland
Own respiration
2.2
8.9
88
404
GD1AD
NOMESCO Finland
Thorax CT examination
2.3
8.8
80
352
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
8.8
164
948
L08
ICPC
Shoulder symptom/complaint
1.4
8.7
439
3205
A07AA02
ATC
nystatin; oral
1.9
8.7
132
714
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.8
8.7
136
746
M03BX02
ATC
tizanidine; oral
1.2
8.7
1577
13715
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
8.6
524
3949
SPAT1101
SPAT
Orthostatic test
2.2
8.6
88
409
T90
ICPC
Diabetes non-insulin dependent
1.4
8.6
438
3208
I34.01
ICD-10 Finland
Mitral (valve) regurgitation NOS or of specified cause, except rheumatic
6.5
8.6
21
32
C09AA02
ATC
enalapril; systemic
1.4
8.6
390
2799
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.6
8.6
199
1230
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.8
8.6
54
194
FKC50
NOMESCO Finland
Repair of mitral valve for insufficiency using prosthetic chord
7.5
8.6
19
25
UDC00
NOMESCO Finland
Ear microscopy
1.6
8.5
205
1278
C09CA06
ATC
candesartan; oral
1.4
8.5
458
3383
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.8
8.5
52
186
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.7
8.5
55
203
J01FA10
ATC
azithromycin; systemic
1.2
8.4
2029
18148
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
8.4
194
1195
ZXD05
NOMESCO Finland
Urgent procedure
1.3
8.4
818
6612
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
8.3
562
4309
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
8.3
158
921
I20.09
ICD-10 Finland
Unstable angina
2.5
8.3
62
249
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.8
8.3
145
823
SPAT1324
SPAT
Screening procedure
1.4
8.3
470
3507
A03
ICPC
Fever
1.3
8.3
600
4651
J01MA02
ATC
ciprofloxacin; systemic
1.3
8.3
890
7278
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.2
8.2
78
350
J01AA02
ATC
doxycycline; systemic
1.2
8.2
2096
18835
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.0
8.2
95
465
E66.00
ICD-10 Finland
Metabolic syndrome
2.0
8.2
99
493
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
2.0
8.2
99
493
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
8.2
472
3530
A10AE05
ATC
insulin detemir; parenteral
1.8
8.2
142
805
WZC30
NOMESCO Finland
Teaching
1.5
8.1
301
2075
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
8.1
134
750
WZA90
NOMESCO Finland
Other doctors statement
1.3
8.0
771
6213
J20
ICD-10 Finland
Acute bronchitis
1.6
8.0
220
1418
FM1DE
SPAT
NA
9.9
8.0
15
15
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
4.8
8.0
25
52
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.0
7.9
97
485
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
2.5
7.9
60
243
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
7.9
604
4713
R55
ICD-10 Finland
Syncope and collapse
1.5
7.9
228
1488
C03DA01
ATC
spironolactone; oral
1.6
7.9
181
1115
E66.01
ICD-10 Finland
Obesity due to excess calories
1.6
7.9
187
1159
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
7.9
214
1378
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.6
7.8
188
1173
R99
ICPC
Respiratory disease other
3.0
7.8
42
139
FM2CE
NOMESCO Finland
NA
2.4
7.8
64
269
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
7.8
246
1639
N06AX21
ATC
duloxetine; oral
1.6
7.7
218
1414
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.4
7.7
354
2542
K02
ICPC
Pressure/tightness of heart
2.9
7.7
44
149
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.7
7.7
143
828
90492
NOMESCO Finland
NA
14.9
7.7
12
8
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
7.6
773
6266
SPAT1081
SPAT
Cardiorespiratory global assessment
1.9
7.6
115
622
SPAT1104
SPAT
Monitoring of emergency patient
1.7
7.6
154
916
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
7.6
201
1286
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.9
7.5
98
503
R06AE09
ATC
levocetirizine; oral
1.4
7.5
416
3087
KMAK
NOMESCO Finland
NA
1.2
7.5
1465
12773
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
4.9
7.5
23
47
I47.1
ICD-10 Finland
Supraventricular tachycardia
2.0
7.5
87
428
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
7.4
206
1332
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
7.4
526
4060
Q23.11
ICD-10 Finland
Bicuspid aortic valve
3.7
7.4
30
80
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
7.4
254
1723
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
7.4
541
4195
SPAT1058
SPAT
PEF monitoring instruction
1.6
7.3
183
1150
A10AA02
ATC
NA
2.2
7.3
74
342
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
7.3
282
1960
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
7.3
1102
9349
SPAT1229
SPAT
Assessment of need for aid
1.7
7.3
155
936
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
5.2
7.3
21
40
K80
ICPC
Cardiac arrhythmia NOS
1.7
7.3
138
807
7862A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Cough
+∞
7.3
7
*
A10AA01
ATC
NA
2.3
7.2
63
272
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
7.2
464
3528
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
7.2
144
856
H03AA01
ATC
levothyroxine sodium; systemic
1.3
7.1
570
4472
M79.1
ICD-10 Finland
Myalgia
1.4
7.1
307
2181
C07AA05
ATC
propranolol; systemic
1.3
7.1
489
3763
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.6
7.0
183
1164
XW000
NOMESCO Finland
Bone marrow biopsy
1.9
7.0
92
474
WX704
NOMESCO Finland
Intubation
1.6
7.0
170
1064
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
7.0
130
757
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.5
7.0
204
1338
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
5.5
7.0
19
34
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.6
7.0
179
1135
ZXE20
NOMESCO Finland
More than three and less than five hours
1.4
7.0
321
2307
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
7.0
447
3397
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.7
6.9
131
765
K29
ICPC
Cardiovascular sympt/complt other
2.1
6.9
76
367
Z01.2
ICD-10 Finland
Dental examination
1.2
6.9
1430
12517
D82
ICPC
Teeth/gum disease
1.2
6.8
1139
9752
A02BC04
ATC
rabeprazole; oral
1.6
6.8
162
1008
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
6.8
159
987
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
2.1
6.8
68
316
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
6.8
148
901
H01
ICPC
Ear pain/earache
1.4
6.7
385
2873
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.6
6.7
161
1005
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
2.1
6.7
70
330
XF602
NOMESCO Finland
Bloodpressure monitoring
3.1
6.7
34
109
M01AC06
ATC
meloxicam; systemic, rectal
1.2
6.7
834
6919
P01AB01
ATC
metronidazole; oral, rectal
1.2
6.7
977
8245
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
6.7
146
891
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
6.7
695
5643
Z94.0
ICD-10 Finland
Kidney transplant status
3.0
6.7
36
121
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
6.7
203
1342
SPAT1240
SPAT
Therapeutic discussion
1.4
6.7
368
2731
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
6.6
326
2373
I35.9
ICD-10 Finland
Aortic valve disorder, unspecified
7.1
6.6
15
21
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
6.6
56
239
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
6.6
479
3707
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.2
6.6
65
301
WX725
NOMESCO Finland
Noninvasive ventilation
1.8
6.6
105
583
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.9
6.6
91
481
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.9
6.6
93
496
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.5
6.6
205
1365
SPAT1202
SPAT
Intra-articular injection
2.1
6.5
67
316
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.4
6.5
251
1746
L28
ICPC
Limited function/disability (L)
1.4
6.5
323
2353
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
6.5
396
2986
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.0
6.5
76
378
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
6.5
1040
8859
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
4.0
6.5
24
60
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.8
6.5
100
550
A01
ICPC
Pain general/multiple sites
1.6
6.5
177
1144
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
6.5
186
1215
SPAT1053
SPAT
Memory test
1.4
6.4
262
1840
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
6.4
375
2810
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
3.0
6.4
34
113
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
2.8
6.4
38
135
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.4
6.4
263
1855
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
6.4
256
1796
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.5
6.4
46
183
SGA01
NOMESCO Finland
Tooth opening as first aid
1.3
6.4
391
2951
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
6.4
165
1051
C09DA01
ATC
losartan and diuretics; oral
1.5
6.4
197
1309
K85
ICPC
Elevated blood pressure
1.4
6.4
294
2117
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.5
6.4
182
1190
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.7
6.3
115
669
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
3.6
6.3
26
72
R07.1
ICD-10 Finland
Chest pain on breathing
3.7
6.3
25
67
SPAT1285
SPAT
Provision of consultation response
1.6
6.3
135
821
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
2.9
6.3
36
124
E0000UV
ATC
NA
1.2
6.2
1219
10583
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.7
6.2
121
713
78330
ICD-8 Finland
Symptoms referable to respiratory system, Cough
+∞
6.2
6
*
J46
ICD-10 Finland
Status asthmaticus
2.3
6.2
52
225
J01FA15
ATC
telithromycin; oral
1.5
6.2
202
1361
L01
ICPC
Neck symptom/complaint
1.4
6.2
353
2638
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.3
6.2
53
229
S97
ICPC
Chronic ulcer skin
1.8
6.1
95
522
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.4
6.1
261
1852
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.9
6.1
83
434
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.7
6.1
122
728
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.5
6.1
179
1176
D07AC01
ATC
betamethasone; topical
1.2
6.1
829
6934
A04
ICPC
Weakness/tiredness general
1.3
6.1
386
2929
I42.1
ICD-10 Finland
Obstructive hypertrophic cardiomyopathy
5.7
6.1
16
28
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
6.1
143
893
L13
ICPC
Hip symptom/complaint
1.4
6.1
332
2464
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
6.1
665
5429
XG466
NOMESCO Finland
Sleep oxymetry
2.4
6.0
47
195
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.4
6.0
265
1890
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.8
6.0
36
129
SPAT1216
SPAT
Assessment of functional ability
1.4
6.0
321
2369
K92.1
ICD-10 Finland
Melaena
1.8
6.0
96
535
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
6.0
200
1351
R06AX27
ATC
desloratadine; oral
1.2
6.0
829
6945
ZXD10
NOMESCO Finland
Scheduled procedure
1.2
6.0
1024
8769
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1127
5410
2.43
129.12
2.8
2.9
ng/l
1189.2
1294.8
0.31
938
4542
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
422
1523
2.92
83.61
2.3
1.8
ug/l
7.3
7.3
0.02
371
1303
(3044889) 12 lead EKG panel
2630
19592
1.82
77.34
3.9
2.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1342
8355
1.85
69.77
3.6
2.5
ng/l
41.6
76.2
0.80
836
4966
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
941
5237
1.99
68.64
2.2
2.0
mg/l
1.3
1.3
0.04
715
3896
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1210
7469
1.83
63.60
2.2
2.0
u/l
215.8
236.1
0.35
1131
7050
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
749
3966
2.05
62.22
3.8
2.7
ng/l
675.3
950.1
0.38
539
2756
(3032080) INR in Blood by Coagulation assay
1459
9778
1.71
56.34
8.2
6.7
inr
1.2
1.2
0.53
428
2894
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
368
1510
2.54
56.12
3.1
2.9
ng/l
166.7
175.2
0.14
336
1349
(3013826) Glucose [Moles/volume] in Serum or Plasma
2275
17139
1.65
55.86
5.9
4.2
mmol/l
6.6
6.5
2.39
2116
15590
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1956
14213
1.65
55.14
8.2
6.4
mmol/l
1.2
1.2
1.19
1667
12085
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1792
12925
1.63
50.69
7.8
6.1
mmol/l
1.2
1.2
1.77
1649
11700
(3013707) Erythrocyte sedimentation rate by Westergren method
2852
23069
1.64
50.03
4.5
3.6
mm/h
11.5
10.8
1.78
2658
21238
(3018677) aPTT in Platelet poor plasma by Coagulation assay
711
3972
1.92
49.67
2.9
2.9
s
29.7
29.9
0.20
690
3858
(3006315) Basophils [#/volume] in Blood
2104
15834
1.60
49.58
7.0
5.9
e9/l
0.0
0.0
1.39
1848
13509
(3001604) Monocytes [#/volume] in Blood
2099
15794
1.60
49.44
6.9
5.9
e9/l
0.6
0.6
0.49
1838
13464
(3013115) Eosinophils [#/volume] in Blood
2154
16377
1.59
48.04
7.2
6.2
e9/l
0.2
0.2
0.20
1920
14197
(3019198) Lymphocytes [#/volume] in Blood
2160
16477
1.59
47.17
7.0
5.9
e9/l
2.0
2.0
0.04
1952
14389
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
706
4012
1.88
46.56
1.9
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1092
7067
1.70
46.24
4.3
3.5
kg/l
1.0
1.0
0.31
142
1065
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1133
7487
1.67
43.99
2.7
2.3
mg/l
2.9
2.8
0.82
1008
6419
(3013650) Neutrophils [#/volume] in Blood by Automated count
2347
18427
1.56
43.88
9.7
8.6
e9/l
4.0
3.9
0.69
2075
15834
(3024561) Albumin [Mass/volume] in Serum or Plasma
1640
11903
1.58
43.19
5.8
4.9
g/l
36.1
36.1
0.11
1538
11019
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1899
14263
1.56
42.95
6.5
5.7
umol/l
11.4
12.1
0.93
1793
13362
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
503
2648
1.99
41.35
1.9
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
1179
7990
1.63
40.93
4.7
3.7
ph
7.4
7.4
1.52
227
1431
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2783
22919
1.55
40.30
8.0
6.4
u/l
83.9
81.7
1.00
2639
21405
(3023103) Potassium [Moles/volume] in Serum or Plasma
3752
33364
1.79
38.52
17.1
11.4
mmol/l
3.9
3.9
0.63
3650
32155
(3019550) Sodium [Moles/volume] in Serum or Plasma
3745
33285
1.79
38.50
17.0
11.4
mmol/l
139.5
139.6
2.21
3649
32176
(3027945) Reticulocytes/100 erythrocytes in Blood
542
3010
1.89
37.85
3.3
3.4
%
1.8
1.7
2.02
483
2693
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
458
2406
1.98
37.73
7.9
7.4
kpa
5.1
5.1
0.20
436
2301
(3027801) Oxygen [Partial pressure] in Arterial blood
457
2405
1.98
37.44
7.9
7.4
kpa
13.2
13.4
0.25
434
2303
(3023368) Bacteria identified in Blood by Culture
1016
6778
1.63
36.99
4.4
3.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
489
2645
1.93
36.95
1.8
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
455
2405
1.97
36.79
7.8
7.4
mmol/l
1.0
0.8
0.63
357
1847
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
582
3335
1.84
36.75
8.1
5.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3511
30784
1.65
36.43
5.1
4.3
mu/l
1.9
2.1
0.96
3262
28396
(3019060) Gas panel - Arterial blood
286
1269
2.31
36.39
5.5
4.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1209
8446
1.57
36.13
3.0
2.3
u/l
57.1
57.0
0.03
1129
7703
(40761535) Cells panel - Urine sediment
418
2167
2.00
35.68
4.4
3.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
413
2141
2.00
35.25
8.3
7.9
%
96.3
96.0
0.26
395
2063
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3066
26153
1.53
34.72
4.3
3.7
pmol/l
14.7
14.6
1.37
2810
23537
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3799
34131
1.77
34.61
15.1
10.1
mg/l
22.5
23.4
0.81
2985
25386
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
504
2815
1.87
34.41
4.1
4.6
u/l
243.2
247.9
0.27
473
2678
(3022948) Iron [Moles/volume] in Serum or Plasma
679
4154
1.73
34.13
3.1
2.3
umol/l
13.0
13.5
1.07
636
3862
(3002173) Hemoglobin [Mass/volume] in Arterial blood
389
1999
2.01
33.99
8.6
7.7
g/l
115.8
120.6
4.44
371
1919
(3023520) Reticulocytes [#/volume] in Blood
412
2175
1.96
33.31
2.9
3.0
e9/l
68.9
67.8
0.23
309
1567
(3008152) Bicarbonate [Moles/volume] in Arterial blood
279
1277
2.24
32.94
8.3
6.7
mmol/l
25.0
24.4
1.69
259
1183
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1945
15261
1.47
32.51
3.3
2.7
ug/l
88.8
92.8
0.46
1823
14236
(3012095) Magnesium [Moles/volume] in Serum or Plasma
666
4110
1.71
32.29
4.2
4.5
mmol/l
0.8
0.8
0.12
633
3838
(3004789) Transferrin [Mass/volume] in Serum or Plasma
618
3742
1.74
32.08
3.1
2.3
g/l
2.4
2.4
0.34
572
3460
(3035350) Ketones [Presence] in Urine by Test strip
1995
15780
1.46
31.69
4.1
3.2
estimate
0.0
0.0
0.50
357
2931
(3015736) pH of Urine
1611
12236
1.48
31.50
3.8
3.0
—
5.6
—
0
6
(40760892) CBC W Ordered Manual Differential panel - Blood
1019
7028
1.56
31.50
5.5
4.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1425
10604
1.49
30.68
7.0
6.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1898
14941
1.45
30.53
7.1
6.1
%
2.8
2.8
0.08
1778
13911
(3019069) Monocytes/100 leukocytes in Blood
1908
15059
1.45
30.13
7.4
6.3
%
8.3
8.4
0.22
1786
14102
(3020779) Urea [Moles/volume] in Serum or Plasma
428
2367
1.87
29.98
9.9
8.0
mmol/l
8.3
8.1
0.41
421
2268
(3019309) Folate [Moles/volume] in Red Blood Cells
705
4508
1.65
29.67
1.8
1.7
nmol/l
1313.9
1158.2
4.01
579
3414
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
570
3451
1.73
29.44
3.2
2.4
%
21.5
22.9
1.48
463
2980
(3012516) Albumin [Mass/volume] in Urine
1006
7022
1.54
29.14
4.0
3.2
mg/l
562.0
332.8
0.70
653
4395
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1473
11121
1.47
29.10
2.0
1.8
pmol/l
95.3
96.6
0.55
799
5687
(3009261) Glucose [Presence] in Urine by Test strip
1999
15984
1.44
29.05
4.1
3.3
estimate
0.0
0.0
0.80
356
2950
(3002030) Lymphocytes/100 leukocytes in Blood
1974
15761
1.43
28.84
7.1
6.0
%
29.9
30.2
0.60
1849
14714
(4010399)
309
1551
2.04
28.72
1.5
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1830
14436
1.44
28.43
7.2
6.2
%
0.7
0.7
0.20
1716
13465
(3018010) Neutrophils/100 leukocytes in Blood
1944
15515
1.43
28.27
6.8
5.9
%
55.4
55.3
0.08
1825
14536
(3029937) Albumin [Presence] in Urine by Test strip
1171
8504
1.49
27.91
4.6
3.5
estimate
0.0
0.0
0.11
339
2901
(3009508) Creatinine [Moles/volume] in Urine
1205
8836
1.48
27.25
4.1
3.3
mmol/l
7.4
7.7
1.17
1057
7614
(3020682) Albumin/Creatinine [Ratio] in Urine
1037
7383
1.51
27.08
4.7
3.9
mg/mmol
15.5
11.1
0.63
665
4677
(3021601) Nitrite [Presence] in Urine by Test strip
1970
15839
1.42
27.07
5.2
4.5
estimate
0.0
0.0
0.50
370
2996
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
366
1993
1.89
26.82
2.5
2.5
ml/min/173m2
65.4
70.5
1.34
151
758
(3015377) Calcium [Moles/volume] in Serum or Plasma
1286
9589
1.46
26.56
3.2
3.1
mmol/l
2.4
2.4
0.46
1153
8401
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1562
12096
1.43
26.25
4.2
3.3
—
—
—
0
0
(3020891) Body temperature
198
869
2.31
25.81
6.0
4.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1034
7423
1.49
25.74
4.2
3.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3880
35644
1.68
25.20
11.0
8.4
u/l
25.0
25.2
0.28
3757
34245
(3031040) Bacteria [#/volume] in Urine by Automated count
2544
21552
1.40
24.90
4.8
3.8
e6/l
3455.5
2713.0
0.08
28
302
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1297
9787
1.44
24.79
3.6
3.1
u/l
31.6
32.7
0.33
1234
9302
(3021960) Folate [Moles/volume] in Serum or Plasma
886
6212
1.51
24.57
1.6
1.4
nmol/l
20.8
20.6
0.10
766
5347
(3014576) Chloride [Moles/volume] in Serum or Plasma
481
2920
1.71
24.37
8.2
7.0
mmol/l
104.3
104.7
1.00
471
2853
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
271
1383
2.00
24.01
9.2
9.4
%
1.3
1.3
0.68
271
1377
(3005322) IgE [Units/volume] in Serum or Plasma
335
1854
1.85
23.27
1.4
1.2
u/ml
275.0
250.3
0.09
306
1708
(3000991) Gas panel - Venous blood
428
2564
1.72
22.71
8.9
8.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
591
3853
1.60
22.53
7.8
6.5
mmol/l
1.1
1.1
2.05
562
3594
(40761511) CBC panel - Blood by Automated count
3894
35998
1.64
22.26
14.3
9.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2600
22342
1.37
21.88
4.6
3.8
—
—
—
0
0
(44790049)
93
305
3.06
21.72
2.0
1.6
—
—
—
0
0
(44790047)
93
305
3.06
21.72
2.0
1.6
—
—
—
0
0
(44806118)
93
305
3.06
21.72
2.0
1.6
—
—
—
0
0
(44790048)
93
305
3.06
21.72
2.0
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
139
563
2.49
21.69
1.8
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1233
9404
1.41
21.60
3.0
2.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
323
1817
1.82
21.26
3.0
2.5
g/l
67.1
66.4
0.77
301
1653
(3007853) Bacteria identified in Skin by Aerobe culture
530
3419
1.61
21.04
1.7
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
373
2198
1.74
20.95
8.0
7.8
mmol/l
1.3
1.4
0.30
359
2096
(3035941) MCH [Entitic mass]
4165
39360
2.00
20.57
22.1
15.2
pg
29.9
30.0
1.53
4115
38678
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
183
855
2.16
20.53
1.4
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
4165
39368
2.00
20.43
22.2
15.3
e12/l
4.5
4.5
13.22
4043
37942
(3000963) Hemoglobin [Mass/volume] in Blood
4166
39385
2.00
20.36
22.4
15.4
g/l
132.6
134.6
18.81
4113
38707
(3024731) MCV [Entitic volume]
4164
39360
1.99
20.35
22.1
15.2
fl
89.8
89.8
0.38
4113
38677
(3007461) Platelets [#/volume] in Blood
4161
39326
1.98
20.28
22.3
15.3
e9/l
258.5
259.1
0.22
4058
38010
(3010813) Leukocytes [#/volume] in Blood
4165
39388
1.99
20.09
22.2
15.3
e9/l
6.8
6.7
0.81
4048
37950
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
180
848
2.14
19.78
1.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
265
1435
1.88
19.69
2.6
2.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
152
672
2.28
19.53
6.0
5.4
mmol/l
1.4
1.3
0.50
130
577
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
99
360
2.76
19.22
1.7
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
226
1178
1.94
18.84
11.2
10.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
791
5692
1.46
18.69
1.7
1.6
pmol/l
24071753.7
25830997.2
0.03
673
4816
(3027273) Bicarbonate [Moles/volume] in Venous blood
206
1044
2.00
18.62
5.9
3.2
mmol/l
25.0
25.0
0.07
189
1003
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
78
254
3.07
18.49
1.4
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
132
564
2.35
18.37
1.9
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
863
6357
1.43
17.89
3.1
2.5
umol/l
2682.1
5210.8
1.62
762
5621
(3036481) Cortisol [Moles/volume] in Serum or Plasma
430
2741
1.61
17.82
2.2
2.2
nmol/l
375.5
380.7
0.19
396
2517
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3041
27164
1.35
17.67
5.7
4.6
mmol/mol
39.2
38.4
5.01
2848
25147
(40768797) Stomach Pathology biopsy report
508
3379
1.55
17.52
1.2
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
251
1387
1.84
17.49
6.3
4.6
g/l
124.7
128.8
1.80
239
1352
(3002032) Base excess in Venous blood by calculation
432
2773
1.60
17.38
6.5
5.4
mmol/l
1.6
1.5
0.19
338
2194
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1607
13134
1.33
17.29
2.6
2.3
nmol/l
75.2
74.9
0.16
1468
11944
(3005719) IgG [Mass/volume] in Serum or Plasma
368
2277
1.65
17.18
2.8
2.8
g/l
10.1
10.2
0.11
336
2085
(3023419) Bacteria identified in Sputum by Culture
59
172
3.42
16.76
2.9
2.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
295
1740
1.72
16.47
1.8
1.9
g/l
1.1
1.3
1.56
270
1596
(3021447) Carbon dioxide [Partial pressure] in Venous blood
429
2790
1.58
16.30
6.6
5.4
kpa
5.9
5.8
1.05
414
2708
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
88
333
2.64
15.88
1.8
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
199
1059
1.90
15.62
1.8
1.8
g/l
1.5
1.5
0.45
172
912
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1120
8785
1.35
15.56
1.4
1.4
u/ml
2.0
2.1
0.11
281
2159
(3022217) INR in Platelet poor plasma by Coagulation assay
405
2628
1.58
15.52
19.0
19.6
inr
1.3
1.3
0.09
62
397
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
82
305
2.69
15.32
1.7
1.4
—
—
—
0
0
(4062490)
72
250
2.88
15.31
1.1
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
645
4641
1.44
14.97
1.3
1.2
u/ml
8.0
12.4
1.23
257
1807
(3002385) Erythrocyte distribution width [Ratio]
3259
29672
1.34
14.94
17.6
12.9
%
13.5
13.5
1.67
3190
28932
(3013512) EKG study
928
7113
1.37
14.87
3.5
3.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3370
30843
1.35
14.86
19.6
13.2
g/l
332.5
332.9
1.74
3349
30553
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
160
805
2.00
14.81
2.1
2.0
ug/l
2.6
2.2
0.14
141
711
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
678
4939
1.42
14.68
1.3
1.2
iu/ml
29.2
31.0
0.10
229
1508
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3298
30109
1.34
14.63
4.4
3.7
mmol/l
5.8
5.7
4.83
3042
27458
(3037522) Nuclear Ab [Titer] in Serum
568
4007
1.46
14.62
1.4
1.4
titre
459.8
609.6
1.10
107
812
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1775
14953
1.29
14.53
4.3
3.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
332
2087
1.62
14.52
5.2
4.3
ng/l
86.4
75.1
1.43
299
1815
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
652
4727
1.43
14.49
2.6
2.8
mmol/l
2.4
2.4
0.19
565
4136
(3048689) Calprotectin [Mass/mass] in Stool
626
4510
1.43
14.40
2.6
2.7
ug/g
120.0
127.3
0.24
481
3541
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
195
1066
1.85
14.10
4.9
4.8
%
1.4
1.2
1.51
195
1056
(3042936) Bacteria identified in Isolate by Culture
525
3673
1.47
14.09
2.0
1.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
372
2423
1.57
14.00
5.5
5.3
kpa
4.9
4.8
0.21
363
2353
(3024139) IgG subclass 3 [Mass/volume] in Serum
69
249
2.77
13.70
1.1
1.4
g/l
0.4
0.4
0.38
47
185
(3028192) IgG subclass 2 [Mass/volume] in Serum
69
249
2.77
13.70
1.1
1.4
g/l
2.7
2.8
0.16
45
186
(3027135) IgG subclass 1 [Mass/volume] in Serum
69
250
2.76
13.60
1.1
1.4
g/l
6.6
6.6
0.06
47
186
(40758558) Short blood count panel - Blood
1014
7972
1.33
13.58
7.2
6.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
967
7562
1.34
13.41
1.6
1.4
g/l
2.1
2.1
0.40
582
4430
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
74
283
2.61
13.14
1.6
1.6
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
189
1049
1.82
13.03
5.0
4.8
%
0.6
0.7
0.20
184
1010
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3333
30641
1.32
12.92
4.4
3.6
mmol/l
4.6
4.7
9.44
3133
28451
(40760888) Immunoglobulin light chains.free panel - Serum
97
424
2.29
12.92
4.2
3.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
116
548
2.12
12.77
3.6
3.8
%
55.8
56.1
0.09
116
548
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2922
26421
1.28
12.74
3.6
3.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
223
1308
1.72
12.73
1.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
117
556
2.11
12.69
2.9
2.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
790
6039
1.36
12.65
3.0
2.4
e6/l
6.5
7.4
0.71
707
5229
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
176
967
1.83
12.55
2.3
1.8
u/l
37.7
40.0
0.86
156
877
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
655
4872
1.39
12.42
3.0
2.6
e6/l
1.1
1.3
0.39
374
2626
(3030467) Casts [#/volume] in Urine by Automated count
1025
8177
1.31
12.19
3.5
2.9
e6/l
0.5
0.4
0.30
776
5950
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3299
30366
1.30
12.12
4.3
3.6
mmol/l
1.5
1.5
0.70
3064
28062
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3172
29085
1.28
11.78
4.0
3.3
mmol/l
1.2
1.2
0.38
2943
26731
(3009445) Proteinase 3 Ab [Units/volume] in Serum
180
1016
1.78
11.77
1.8
1.6
u/ml
10.6
11.8
—
7
38
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
117
573
2.05
11.74
2.3
1.9
mg/l
10.3
11.1
0.39
109
531
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
190
1095
1.75
11.57
4.2
4.9
%
92.6
92.6
0.01
183
1031
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3358
31041
1.30
11.56
4.8
4.0
mmol/l
2.7
2.8
14.00
3120
28631
(3024980) IgG subclass 4 [Mass/volume] in Serum
94
428
2.20
11.40
1.3
1.7
g/l
0.8
0.8
0.02
66
342
(3039000) Anion gap in Blood
100
469
2.13
11.26
7.6
6.5
mmol/l
10.6
11.3
1.19
88
413
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
107
516
2.08
11.21
4.8
5.2
u/ml
352.2
1216.2
—
5
39
(3018572) Chloride [Moles/volume] in Blood
100
470
2.13
11.21
7.6
6.5
mmol/l
105.1
105.1
0.02
88
414
(3009343) pH of Capillary blood
324
2153
1.53
11.13
5.9
5.7
ph
7.4
7.4
0.62
33
176
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
284
1833
1.57
11.13
1.6
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
317
2106
1.53
10.91
5.9
5.7
mmol/l
1.4
1.3
0.39
231
1502
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
297
1946
1.55
10.89
3.1
3.4
pmol/l
4.6
4.6
0.21
269
1764
(3012501) Base excess in Blood by calculation
107
524
2.04
10.77
3.9
4.0
mmol/l
2.3
2.6
0.66
71
325
(3023183) Ammonium ion [Moles/volume] in Plasma
118
599
1.97
10.75
3.4
3.0
umol/l
34.0
33.5
0.11
106
527
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
115
580
1.99
10.68
3.9
3.3
ratio
1.3
1.6
—
7
57
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
324
2174
1.51
10.64
6.0
5.7
kpa
5.1
5.1
0.44
307
2044
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
118
602
1.96
10.60
3.9
3.3
mg/l
34.1
54.3
0.84
94
500
(3034860) Kappa light chains.free [Mass/volume] in Serum
118
603
1.96
10.56
3.9
3.3
mg/l
41.7
54.6
0.62
94
506
(3010421) pH of Blood
119
610
1.95
10.55
3.8
3.9
ph
7.4
7.4
1.19
107
514
(3021589) Normoblasts [#/volume] in Blood
1724
14860
1.24
10.54
10.4
8.3
e9/l
0.0
0.0
0.95
1430
11950
(3009542) Hematocrit [Volume Fraction] of Blood
3530
32967
1.30
10.45
15.4
11.5
%
39.5
39.7
0.78
2494
25531
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
62
245
2.52
10.38
1.8
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
154
865
1.79
10.28
1.8
1.7
g/l
0.2
0.2
0.01
146
827
(36304419) Bacteria [Presence] in Urine
1000
8119
1.28
10.14
3.5
2.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
157
891
1.77
10.12
1.8
1.7
g/l
1.2
1.2
0.10
150
857
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
87
406
2.14
9.97
1.6
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
60
240
2.49
9.82
1.7
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
54
206
2.61
9.74
2.4
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1084
8936
1.26
9.63
3.7
3.0
e6/l
110.6
72.8
0.30
841
6591
(3036489) Thrombin time
193
1181
1.64
9.47
3.7
3.3
s
22.5
21.7
0.96
168
1041
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
120
642
1.87
9.40
9.4
5.7
iu/ml
314.6
402.2
0.24
18
75
(3017181) Myelocytes/100 leukocytes in Blood
337
2343
1.46
9.28
4.6
4.2
%
1.0
0.8
0.40
103
625
(3007930) Methemoglobin/Hemoglobin.total in Blood
146
836
1.75
9.16
6.3
4.8
%
1.0
0.9
0.59
132
774
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
172
1036
1.67
8.98
4.5
4.2
g/l
3.3
3.4
0.63
167
992
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
46
169
2.71
8.95
1.5
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
46
169
2.71
8.95
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
46
169
2.71
8.95
1.5
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
183
1128
1.63
8.74
10.5
10.0
mmol/l
24.0
24.1
0.26
173
1072
(3011985) Renin [Units/volume] in Plasma
70
318
2.19
8.63
1.4
1.5
mu/l
56.5
81.6
0.33
64
280
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
146
853
1.72
8.56
6.2
4.8
%
1.6
1.6
0.12
131
785
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
918
7513
1.26
8.53
1.8
1.6
mmol/l
1.3
1.3
0.11
759
6497
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
76
359
2.11
8.50
1.4
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
125
700
1.79
8.49
1.4
1.4
ug/g
275.2
283.4
0.17
75
368
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
138
797
1.73
8.43
1.7
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
140
813
1.73
8.39
1.6
1.6
titre
186.7
372.1
—
6
38
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
122
681
1.79
8.38
3.9
6.8
u/ml
0.4
0.4
0.17
78
375
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
273
1861
1.48
8.33
6.0
6.3
mmol/l
23.9
23.8
0.21
251
1744
(3013139) Helicobacter pylori Ag [Presence] in Stool
274
1870
1.48
8.31
1.2
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
131
754
1.74
8.12
1.7
1.7
u/ml
107.7
113.3
0.23
26
128
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
220
1442
1.53
8.11
1.5
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
303
2122
1.44
8.05
3.6
3.5
mmol/l
1.2
1.2
0.35
264
1812
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
158
960
1.65
8.02
5.4
3.5
%
176.4
177.0
0.04
153
932
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
25
68
3.65
8.01
7.1
3.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
69
322
2.14
7.99
1.3
1.3
nmol/l
0.1
0.4
—
5
20
(3015235) Bicarbonate [Moles/volume] in Capillary blood
112
619
1.81
7.97
6.3
4.2
mmol/l
23.7
24.4
1.33
103
547
(3037756) Immunofixation for Serum or Plasma
81
403
2.00
7.92
1.8
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
92
480
1.91
7.85
2.3
2.5
%
16.3
16.8
0.49
41
246
(3024928) Oxygen saturation in Venous blood
97
516
1.88
7.80
5.6
7.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
127
736
1.73
7.70
1.3
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
425
3177
1.36
7.70
3.8
3.3
umol/l
8.3
7.9
0.13
371
2725
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
158
974
1.63
7.59
5.0
3.7
%
56.7
49.3
3.20
158
955
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
155
957
1.62
7.41
1.4
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
894
7401
1.24
7.40
4.8
3.9
%
90.5
92.2
1.30
872
7242
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
189
1231
1.54
7.20
2.4
2.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
84
440
1.90
7.12
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
60
278
2.15
7.11
1.3
1.3
nmol/l
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
375
2791
1.36
6.99
2.8
2.7
g/l
0.2
0.2
0.37
357
2635
(3015171) Extractable nuclear Ab [Units/volume] in Serum
169
1081
1.57
6.99
1.2
1.3
u/ml
2.0
1.2
0.22
19
87
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1070
9090
1.22
6.85
1.8
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
23
66
3.46
6.84
1.1
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
420
3196
1.33
6.76
1.6
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
299
2157
1.40
6.76
4.1
3.9
%
0.6
0.6
0.07
67
460
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
103
585
1.76
6.75
1.6
1.8
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
63
304
2.06
6.75
1.4
1.4
pmol/l
297.4
356.6
0.44
51
241
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
94
521
1.80
6.69
1.9
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
102
582
1.75
6.59
1.3
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
594
4755
1.27
6.53
1.8
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
391
2961
1.34
6.51
1.3
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2320
21173
1.18
6.49
3.4
2.9
u/l
44.7
39.2
1.78
2187
19866
(1616796) Gas panel - Central venous blood
96
541
1.77
6.48
3.8
3.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
146
920
1.59
6.47
1.4
1.5
u/ml
258.9
213.3
0.93
86
498
(3018095) Leukocytes [#/volume] in Urine
1265
10976
1.20
6.41
4.3
3.4
e6/l
109.2
101.6
0.10
908
7174
(3010144) Erythrocytes [#/volume] in Synovial fluid
48
213
2.24
6.36
1.4
1.4
e6/l
19823.6
45484.6
0.37
28
148
(3022313) Gas panel - Capillary blood
243
1709
1.43
6.36
6.0
5.9
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
234
1637
1.44
6.30
5.6
6.0
mmol/l
24.6
24.3
1.20
227
1570
(3042733) HLA Ab [Presence] in Serum
28
96
2.89
6.27
4.2
4.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
134
834
1.61
6.26
2.5
2.3
ug/l
527.8
803.2
0.46
123
771
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
75
397
1.88
6.21
1.4
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
46
203
2.25
6.19
1.1
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
80
434
1.84
6.14
1.2
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
578
4645
1.26
6.14
3.1
2.7
e6/l
2.5
3.4
1.50
298
2406
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
95
543
1.75
6.13
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
95
543
1.75
6.13
1.3
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
46
204
2.24
6.12
1.1
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
29
103
2.79
6.11
1.9
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
126
778
1.62
6.09
2.7
2.2
g/l
3.2
3.1
0.14
100
599
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
127
788
1.61
6.02
1.8
1.9
iu/l
3.3
5.0
1.66
50
275
(3042111) Morphology [Interpretation] in Bone marrow Narrative
74
395
1.87
5.98
1.6
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
292
2144
1.37
5.96
4.7
4.2
%
0.1
0.3
0.69
72
508
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
131
831
1.58
5.69
2.7
2.2
g/l
3.8
3.8
0.13
98
577
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
131
832
1.57
5.66
2.7
2.2
g/l
7.7
7.5
0.64
102
617
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
131
832
1.57
5.66
2.7
2.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
171
1155
1.48
5.57
1.2
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
74
405
1.82
5.56
4.4
3.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
879
7460
1.21
5.56
2.5
2.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
122
766
1.59
5.54
2.5
2.2
g/l
9.9
10.2
0.42
104
644
(3021440) Promyelocytes/100 leukocytes in Blood
302
2258
1.35
5.50
4.8
4.2
%
0.2
0.2
0.18
88
589
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
58
294
1.96
5.50
1.4
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
137
889
1.54
5.40
1.8
1.9
—
—
—
0
0
(4034850)
134
868
1.54
5.33
12.2
7.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
150
1004
1.49
5.13
1.6
1.6
iu/ml
0.1
0.9
0.56
32
203
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
56
288
1.93
5.12
1.6
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
16
44
3.60
5.10
1.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
26
97
2.66
5.04
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
48
235
2.03
5.04
1.6
2.6
e6/l
575.4
743.5
—
10
78
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
21
70
2.97
4.98
8.3
6.9
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
30
121
2.46
4.98
1.4
1.2
nmol/l
137.3
131.6
0.27
30
121
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
67
369
1.81
4.97
1.6
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
46
223
2.05
4.96
4.8
2.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
76
435
1.74
4.96
1.7
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
325
2495
1.31
4.95
2.3
2.3
u/l
7001.3
6553.4
0.06
109
967
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
102
632
1.61
4.94
2.0
2.2
g/l
0.0
0.0
0.11
95
585
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
30
122
2.44
4.90
1.2
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
23
82
2.78
4.86
7.8
7.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
408
3235
1.27
4.85
1.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
193
1374
1.41
4.79
1.9
1.8
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
26
101
2.55
4.68
1.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
15
42
3.54
4.67
1.0
1.0
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
116
753
1.54
4.62
1.8
1.7
mmol/l
3.5
3.6
0.63
108
704
(3025941) Bacteria identified in Stool by Culture
244
1817
1.35
4.61
1.2
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
112
722
1.55
4.61
2.2
2.3
g/l
0.4
0.8
0.95
98
624
(3017732) Neutrophils [#/volume] in Blood
282
2152
1.32
4.51
2.3
2.5
e9/l
4.1
4.1
0.10
240
1724
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
27
109
2.46
4.50
1.2
1.1
%
95.3
92.6
0.27
15
46
(40768446) Kidney Pathology biopsy report
33
146
2.24
4.50
2.4
1.7
—
—
—
0
0
(3000492) Spirometry study
314
2433
1.30
4.49
1.4
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
32
140
2.27
4.48
5.0
4.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
151
1042
1.45
4.48
11.4
9.9
mg/l
1.4
1.2
1.41
143
989
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
40
192
2.07
4.46
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1002
8756
1.17
4.43
3.4
2.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
214
1574
1.36
4.40
1.3
1.3
miu/ml
204.4
236.1
0.67
106
746
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
92
575
1.59
4.34
1.8
2.2
g/l
0.0
0.0
0.00
85
531
(3000093) Morphology [Interpretation] in Blood Narrative
48
249
1.92
4.33
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
40
195
2.04
4.30
1.4
1.5
%
26.5
34.7
0.58
22
132
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
91
569
1.59
4.29
1.8
2.2
g/l
0.0
0.0
0.00
85
530
(3014765) Yersinia sp identified in Stool by Organism specific culture
134
913
1.46
4.26
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
133
905
1.47
4.26
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
757
6484
1.19
4.25
1.5
1.5
—
—
—
0
0
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
14
40
3.47
4.24
1.6
1.6
mg/l
2.5
1.4
—
8
28
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
14
40
3.47
4.24
1.6
1.6
mg/l
0.7
1.0
—
9
32
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
14
40
3.47
4.24
1.6
1.6
mg/l
2.3
4.4
—
8
32
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
14
40
3.47
4.24
1.6
1.6
mg/l
2.0
5.1
—
9
31
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
341
2691
1.27
4.24
3.3
2.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
44
224
1.95
4.20
1.1
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
668
5670
1.19
4.15
3.0
2.5
mosm/kgh2o
545.5
557.3
0.65
583
4764
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
50
267
1.86
4.15
1.4
1.6
%
60.0
57.8
0.13
29
186
(3044640) Blood type and Crossmatch panel - Blood
1109
9814
1.16
4.12
2.5
2.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1064
9388
1.16
4.11
2.1
2.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
246
1870
1.32
4.07
1.3
1.2
au/ml
16.5
42.6
—
6
73
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
622
5263
1.20
4.00
5.1
4.8
ug/l
2.6
3.8
0.79
560
4690
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
72
433
1.65
3.99
2.0
1.7
pmol/l
199.5
192.8
0.10
64
415
(3008116) Ketones [Moles/volume] in Urine by Test strip
13
37
3.48
3.97
1.2
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
47
250
1.87
3.96
6.4
11.4
%
10.9
11.3
0.33
47
250
(3017704) Immunofixation for Urine
25
104
2.38
3.94
1.6
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
51
279
1.82
3.94
2.4
2.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
86
544
1.57
3.90
2.9
2.3
ug/min
107.4
75.6
0.52
46
338
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
74
452
1.63
3.87
3.7
3.1
u/ml
7.9
937.5
0.76
65
413
(4146454)
46
245
1.86
3.87
3.5
2.6
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
25
105
2.36
3.87
1.4
1.2
%
98.7
87.6
0.74
13
45
(42529406) Shigella sp [Presence] in Stool by Culture
133
924
1.44
3.86
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
352
2825
1.25
3.82
4.2
3.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
88
564
1.55
3.78
1.9
1.7
e6/l
14404.8
11292.4
0.30
71
407
(3038071) Oxygen [Partial pressure] in Mixed venous blood
18
65
2.74
3.76
6.4
6.8
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
11
29
3.76
3.73
9.4
9.8
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
83
527
1.57
3.72
1.3
1.4
u/l
19.9
19.7
0.01
67
451
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
28
126
2.20
3.72
5.0
3.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
119
816
1.45
3.71
1.3
1.4
titre
68.0
138.5
—
5
78
(3048929) Epstein Barr virus Ab [Presence] in Serum
240
1844
1.30
3.71
1.5
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
59
345
1.70
3.66
2.3
2.6
e9/l
1.1
1.3
0.76
42
209
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
56
323
1.72
3.65
1.5
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
502
4201
1.20
3.65
5.0
4.2
%
22.0
21.7
0.17
242
2040
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
103
690
1.49
3.62
1.6
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3102
29484
1.14
3.61
12.7
9.4
ml/min/173m2
88.2
88.2
0.02
2467
22954
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
44
237
1.84
3.60
1.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
264
2063
1.28
3.59
2.5
2.3
au/ml
28.2
21.0
—
10
153
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
52
296
1.75
3.56
2.3
2.5
%
11.5
11.0
0.11
31
191
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
98
653
1.49
3.54
1.8
2.1
g/l
38.6
37.9
0.65
90
555
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
31
149
2.06
3.51
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
359
2916
1.24
3.51
1.6
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
121
842
1.43
3.51
1.9
1.7
mg/l
421.3
500.3
1.48
115
795
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
171
2237
0.75
3.50
1.3
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
40
211
1.88
3.50
1.1
1.1
iu/ml
6.0
7.9
—
8
58
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
146
1051
1.39
3.49
1.1
1.1
u/ml
20.4
7.1
0.51
15
134
(3009214) Lutropin [Units/volume] in Serum or Plasma
180
1340
1.34
3.49
1.6
1.7
u/l
8.6
8.9
0.14
137
1037
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
198
1495
1.32
3.48
1.5
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
90
592
1.51
3.47
1.2
1.3
u/ml
1.4
2.0
—
8
44
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
14
46
3.01
3.45
3.7
2.8
mg/l
36.2
17.6
—
5
13
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
29
137
2.10
3.44
1.1
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
63
383
1.63
3.40
1.1
1.3
u/ml
18.3
46.6
—
5
25
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
295
2354
1.26
3.39
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
323
2607
1.24
3.36
1.3
1.2
iu/ml
176.7
159.1
0.24
119
927
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
841
7394
1.15
3.36
1.8
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
155
1135
1.36
3.36
2.0
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
71
447
1.58
3.34
1.3
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
19
77
2.44
3.21
1.4
1.5
nmol/l
137.0
131.1
0.05
14
54
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
31
155
1.98
3.19
1.3
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
109
759
1.43
3.18
2.1
1.8
e6/l
17.0
33.4
0.65
90
569
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
45
255
1.75
3.16
1.1
1.1
—
36.0
—
0
7
(3003181) Sodium [Moles/volume] in Urine
67
422
1.58
3.16
1.7
1.7
mmol/l
61.4
65.7
0.32
55
345
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
109
761
1.43
3.14
2.1
1.9
e6/l
879.0
5782.6
0.49
93
600
(3026389) Candida sp identified in Specimen by Organism specific culture
71
456
1.55
3.09
1.5
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
232
1821
1.27
3.09
1.5
1.6
iu/l
20.2
22.5
0.53
189
1489
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
29
144
2.00
3.05
2.8
2.5
%
43.5
43.2
—
10
50
(3030313) Adrenal Ab [Titer] in Serum
12
39
3.05
3.02
1.2
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
88
597
1.47
2.97
1.5
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
65
416
1.55
2.89
4.2
3.4
%
1.4
1.3
0.13
50
331
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
30
154
1.93
2.89
8.5
2.0
%
131.4
121.0
0.50
30
146
(3037692) Legionella sp identified in Specimen by Organism specific culture
13
46
2.80
2.85
1.2
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
265
3192
0.81
2.85
1.6
1.5
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
38
212
1.78
2.85
3.0
2.9
umol/l
1.8
1.8
0.10
38
206
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
190
1473
1.29
2.82
1.9
1.9
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
55
341
1.60
2.81
1.1
1.1
—
85.0
—
0
5
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
25
122
2.03
2.78
1.6
1.5
u/l
15.8
13.4
0.80
25
117
(3025018) Bordetella pertussis Ab [Titer] in Serum
35
192
1.81
2.77
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
156
1183
1.31
2.74
1.8
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
90
625
1.43
2.72
1.2
1.2
u/ml
38.2
41.2
—
8
64
(3020961) Endomysium IgA Ab [Titer] in Serum
259
2093
1.24
2.72
1.2
1.2
titre
44.0
208.9
—
5
81
(4198724)
42
245
1.70
2.71
1.4
3.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1323
12114
1.11
2.71
2.0
2.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
137
1.95
2.71
1.3
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
139
1039
1.33
2.70
2.0
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
37
209
1.76
2.68
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
415
3517
1.18
2.66
1.8
1.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
70
467
1.49
2.61
1.5
1.3
u/ml
3.7
3.9
0.03
26
173
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
10
32
3.09
2.59
1.5
1.8
ng/l
83.4
112.1
—
10
32
(3000012) Reticulocyte production index
25
126
1.97
2.57
1.6
1.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
13
49
2.63
2.56
1.4
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
104
750
1.38
2.56
1.3
1.3
u/ml
11.0
9.2
0.13
14
123
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
46
280
1.63
2.56
2.0
2.7
e6/l
422.9
490.0
0.63
36
214
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
103
742
1.38
2.55
1.3
1.3
u/ml
4.0
4.9
0.21
11
82
(3035320) C reactive protein [Mass/volume] in Body fluid
38
220
1.71
2.54
2.3
2.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
26
134
1.92
2.51
1.2
1.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
10
33
3.00
2.47
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1187
10854
1.11
2.46
1.5
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
232
1876
1.23
2.45
2.4
2.0
nmol/l
10.8
11.2
0.26
200
1626
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
48
300
1.59
2.42
3.7
4.8
u/ml
242.4
87.4
0.39
14
90
(3023511) Choriogonadotropin [Units/volume] in Urine
168
1311
1.28
2.41
1.5
1.3
—
—
—
0
0
(3019225) pH of Specimen
321
2686
1.20
2.40
4.3
3.7
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
12
45
2.64
2.39
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
251
2055
1.22
2.36
2.8
2.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
56
365
1.52
2.36
1.5
2.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
33
188
1.74
2.35
1.5
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
35
203
1.71
2.35
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
66
446
1.47
2.34
2.5
2.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
18
84
2.12
2.28
1.1
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
40
243
1.63
2.27
2.9
2.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
15
65
2.29
2.25
1.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
17
78
2.16
2.24
2.8
2.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
43
268
1.59
2.21
1.3
1.1
u/l
75.0
115.1
0.59
33
185
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
12
47
2.53
2.21
6.8
6.1
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
12
47
2.53
2.21
7.7
6.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
31
177
1.74
2.21
4.5
7.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
44
276
1.58
2.21
1.6
1.3
promille
1.1
1.2
0.19
37
208
(3024263) Appearance of Synovial fluid
22
113
1.93
2.18
1.7
2.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
45
286
1.56
2.15
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
530
4659
1.14
2.14
2.3
2.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
63
431
1.45
2.13
1.5
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
19
3.65
2.12
1.3
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
58
393
1.46
2.07
2.0
2.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
33
196
1.67
2.07
1.5
1.3
u/ml
0.7
1.5
0.40
17
57
(3035637) Corticotropin [Mass/volume] in Plasma
67
467
1.42
2.06
1.6
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
78
559
1.39
2.05
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
97
720
1.34
2.05
2.2
1.9
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
34
204
1.65
2.05
1.3
1.3
nmol/l
1.5
1.4
0.05
28
190
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
24
131
1.82
2.00
1.2
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
13
56
2.30
1.99
2.8
4.3
—
—
—
0
0
(1002224) Polysomnography panel
126
975
1.29
1.99
1.1
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
43
276
1.55
1.99
2.0
2.7
e9/l
0.2
0.2
0.56
36
215
(3024932) HLA-DR beta [Type]
21
110
1.89
1.98
1.1
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
30
176
1.69
1.97
1.7
1.6
u/l
5.3
4.3
0.24
18
89
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
442
3862
1.15
1.96
2.1
2.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
14
63
2.20
1.95
1.5
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
299
2538
1.18
1.95
2.6
2.2
u/l
33.8
57.3
0.65
252
2149
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
26
147
1.75
1.95
1.0
1.1
nmol/l
0.1
11.8
—
5
39
(21494814) CD8 cells/100 lymphocytes in Specimen
20
104
1.90
1.93
2.4
2.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
12
51
2.33
1.90
1.7
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
21
112
1.86
1.89
1.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
105
1.89
1.89
1.3
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
105
1.89
1.89
1.3
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
20
105
1.89
1.89
1.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
105
1.89
1.89
1.3
1.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
45
2.42
1.88
1.9
2.9
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
140
0.35
1.87
2.6
3.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
290
2465
1.17
1.87
3.7
4.0
ug/l
32.7
20.4
0.29
227
1928
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
26
149
1.73
1.87
1.6
1.7
nmol/l
1.1
7.5
1.27
21
121
(3030981) Hyaline casts [#/volume] in Urine by Automated count
168
1357
1.23
1.86
3.1
2.7
e6/l
0.3
0.3
0.23
162
1318
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
21
113
1.84
1.85
1.2
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
21
113
1.84
1.85
1.2
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
13
59
2.18
1.79
1.1
2.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
27
159
1.68
1.78
1.7
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
167
0.41
1.77
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
59
416
1.41
1.75
1.2
1.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
50
342
1.45
1.75
1.1
1.1
g/l
1.5
1.5
0.32
44
309
(3013727) Leukocytes other/100 leukocytes in Blood
18
94
1.90
1.74
6.0
3.6
%
50.1
51.0
0.05
18
89
(4268621)
47
318
1.47
1.74
2.7
2.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
159
1289
1.23
1.73
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
35
223
1.56
1.71
1.5
1.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
31
192
1.60
1.70
1.6
2.8
e6/l
217.9
300.6
0.88
19
111
(3006184) Hemoglobin [Mass/volume] in Capillary blood
81
605
1.33
1.70
2.4
2.2
g/l
126.0
130.1
0.79
61
458
(3028707) Methadone [Presence] in Urine by Screen method
134
1069
1.25
1.69
3.6
2.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
19
103
1.83
1.65
1.8
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
19
103
1.83
1.65
1.8
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
753
6862
1.10
1.65
2.3
2.3
—
—
—
0
0
(4212803)
6
19
3.12
1.64
1.0
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
10
42
2.36
1.63
1.2
1.1
ug/l
13.6
15.3
—
5
22
(3024891) Influenza virus A+B Ag [Presence] in Specimen
113
889
1.26
1.62
1.2
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
13
62
2.08
1.60
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
76
568
1.33
1.60
1.1
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
33
211
1.55
1.60
1.4
1.3
g/l
34.3
33.0
0.24
28
198
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
5
14
3.53
1.59
6.6
4.4
—
—
—
0
0
(3025315) Body weight
5
14
3.53
1.59
3.2
4.3
—
—
—
0
0
(4094501)
65
476
1.35
1.57
1.1
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
25
150
1.65
1.56
6.4
2.7
umol/l
76.8
210.5
2.09
14
83
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
10
43
2.30
1.56
1.1
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
18
98
1.82
1.56
1.6
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
42
285
1.46
1.56
1.5
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
312
3497
0.87
1.55
1.2
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
41
278
1.46
1.53
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
27
167
1.60
1.51
1.4
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
17
92
1.83
1.50
1.6
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
114
1.74
1.50
1.8
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
207
1750
1.18
1.48
1.7
1.6
mu/l
307.5
319.0
0.27
191
1575
(3020874) Milk IgE Ab [Units/volume] in Serum
45
313
1.43
1.48
1.2
1.2
u/ml
2.2
3.5
0.30
22
150
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
53
380
1.38
1.47
1.2
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
30
192
1.55
1.47
1.2
1.2
u/ml
285.3
23.8
0.43
19
132
(3052851) Hemolysis interference index of Serum or Plasma
103
814
1.26
1.45
4.1
2.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
47
642
0.72
1.45
4.4
3.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
277
2401
1.15
1.44
1.4
1.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
10
45
2.20
1.42
1.0
1.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
5
16
3.09
1.42
1.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
45
316
1.41
1.42
1.4
1.3
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
9
39
2.28
1.41
1.7
1.4
nmol/l
8.5
858072.9
—
9
31
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
21
124
1.68
1.41
1.2
1.1
u/l
23.4
21.7
0.09
16
88
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
11
52
2.09
1.40
1.9
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
44
309
1.41
1.39
1.4
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
17
95
1.77
1.38
2.1
2.0
umol/l
19.5
17.9
0.14
17
95
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
7
29
2.39
1.37
1.1
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
120
973
1.23
1.36
1.2
1.1
u/ml
2.9
2.9
0.00
60
463
(3047352) Trisomy 18 risk [Likelihood] in Fetus
102
1242
0.81
1.35
1.5
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
105
1274
0.81
1.35
1.5
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
811
7488
1.09
1.35
2.4
2.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
130
1543
0.83
1.34
1.5
1.4
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
17
2.91
1.34
1.0
2.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
17
2.91
1.34
1.2
1.3
umol/24h
439.4
308.1
—
5
17
(3019768) Coxiella burnetii Ab [Presence] in Serum
5
17
2.91
1.34
1.0
1.0
—
—
—
0
0
(44813793)
39
271
1.43
1.32
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
24
150
1.58
1.32
1.1
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
8
33
2.40
1.30
1.4
4.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
104
836
1.24
1.29
1.1
1.1
u/ml
3.6
2.7
0.20
34
250
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
145
1696
0.84
1.29
1.5
1.5
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
11
54
2.02
1.29
1.0
1.1
u/ml
4.1
1.6
—
5
42
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
26
167
1.54
1.28
1.3
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
8
34
2.33
1.28
1.4
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
132
1555
0.83
1.27
1.5
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
15
83
1.79
1.26
1.3
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
132
1553
0.84
1.26
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
132
1553
0.84
1.26
1.5
1.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
14
76
1.82
1.25
4.9
4.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
16
91
1.74
1.24
1.1
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
31
209
1.47
1.23
1.2
1.2
ratio
1.0
1.1
0.94
14
83
(3012898) Urea [Moles/volume] in Urine
6
25
2.37
1.22
1.5
1.7
mmol/l
136.8
170.1
—
6
20
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
99
1.70
1.22
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
21
130
1.60
1.21
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
61
464
1.30
1.20
1.5
1.3
u/ml
5.5
4.1
0.39
25
203
(3003888) Timothy IgE Ab [Units/volume] in Serum
108
880
1.22
1.20
1.1
1.1
u/ml
11.0
7.1
0.98
68
514
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
19
2.60
1.20
3.0
2.5
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
12
63
1.88
1.19
1.0
1.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
43
311
1.37
1.18
1.2
1.2
u/ml
2.4
7.2
0.95
20
136
(3025468) Yersinia sp identified in Specimen by Organism specific culture
47
345
1.35
1.18
1.3
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
22
139
1.57
1.17
1.1
1.0
—
—
—
0
0
(3032641) Amino acids panel - Urine
6
26
2.28
1.17
1.2
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
47
346
1.35
1.16
1.3
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
47
346
1.35
1.16
1.3
1.4
u/l
66.8
40.9
0.57
39
294
(3005033) Fetal Nuchal fold Thickness US
104
1240
0.82
1.16
1.5
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
50
372
1.33
1.16
1.5
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
34
0.00
1.15
0.0
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
29
196
1.47
1.15
1.3
1.4
e6/l
2131.6
2490.4
0.20
21
142
(3005988) Vibrio sp identified in Specimen by Organism specific culture
47
347
1.34
1.15
1.3
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
93
751
1.23
1.14
3.4
2.7
umol/l
9.9
7.9
0.34
80
568
(3002621) Streptococcal DNAse B [Units/volume] in Serum
12
64
1.86
1.14
1.4
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
37
263
1.39
1.14
1.1
1.1
u/ml
0.4
2.3
—
10
52
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
36
0.00
1.13
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
10
50
1.98
1.13
1.4
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
136
1142
1.18
1.12
4.3
4.4
g/l
0.4
0.4
0.03
75
561
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
47
349
1.33
1.11
1.3
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
87
1.71
1.11
11.2
14.6
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
40
1.98
1.10
13.2
7.2
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
12
65
1.83
1.09
1.3
2.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
63
489
1.28
1.09
4.0
3.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
24
158
1.50
1.09
1.2
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
58
1.88
1.08
2.0
2.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
40
293
1.35
1.04
1.5
1.2
—
38.4
—
0
7
(3023410) Appearance of Cerebral spinal fluid
52
397
1.30
1.03
2.5
2.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
47
354
1.32
1.03
1.3
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
52
1.90
1.03
1.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
16
97
1.63
1.02
4.7
1.9
mmol/l
8.5
9.8
—
10
75
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
16
97
1.63
1.02
1.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
22
2.25
1.02
1.2
1.3
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
5
22
2.25
1.02
1.4
1.3
—
778.1
—
0
6
(21494434) Karyotype in Bone marrow
34
244
1.38
1.01
1.1
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
232
2046
1.13
1.00
2.7
2.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
176
1525
1.15
1.00
1.6
1.6
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
25
170
1.46
0.99
1.4
1.4
pmol/l
89.0
63.6
—
10
52
(3008401) Mugwort IgE Ab [Units/volume] in Serum
102
847
1.19
0.98
1.1
1.1
u/ml
0.8
1.6
1.13
54
425
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
53
1.87
0.98
1.0
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
179
1.44
0.97
1.3
1.3
e6/l
16410.9
65697.9
0.75
15
101
(1761868) Lipid panel - Serum or Plasma
1073
11091
0.94
0.97
2.7
2.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
46
349
1.31
0.97
1.3
1.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
28
196
1.41
0.96
1.3
1.2
—
56.1
—
0
12
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
16
99
1.60
0.96
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
60
737
0.80
0.94
3.1
2.9
mg/l
16.7
25.3
2.56
39
452
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
34
248
1.36
0.93
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
34
248
1.36
0.93
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
34
248
1.36
0.93
1.1
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
15
92
1.61
0.93
1.2
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
21
140
1.48
0.92
1.1
1.4
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
46
353
1.29
0.91
1.7
1.4
umol/l
4.6
5.7
1.09
41
329
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
112
950
1.17
0.87
1.6
1.8
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
11
63
1.73
0.87
1.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
15
94
1.58
0.86
1.3
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
34
252
1.34
0.86
1.1
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
59
472
1.24
0.85
1.5
1.6
mmol/l
7.3
7.3
0.04
35
281
(3045424) Erythrocytes [Presence] in Urine
63
508
1.23
0.84
1.4
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
14
87
1.59
0.84
1.6
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
17
111
1.52
0.83
1.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
15
95
1.56
0.83
1.1
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
41
315
1.29
0.82
2.1
6.3
mmol/l
7.0
7.1
0.04
35
253
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
15
96
1.55
0.80
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
21
145
1.43
0.80
2.9
2.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
153
1340
1.13
0.79
1.5
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
38
291
1.29
0.79
2.0
2.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
71
586
1.20
0.77
1.3
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
202
1802
1.11
0.77
4.3
2.6
—
—
—
0
0
(4306422)
57
461
1.22
0.76
1.3
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
23
2.15
0.75
1.0
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
23
2.15
0.75
4.8
8.5
mmol/l
4.8
6.7
—
5
23
(3032057) Clostridioides difficile [Presence] in Stool
9
52
1.71
0.75
2.3
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
88
743
1.17
0.75
2.3
2.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
84
707
1.18
0.75
1.6
1.5
nmol/l
0.4
0.4
0.04
68
577
(4281824)
26
343
0.75
0.74
1.2
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
42
329
1.26
0.74
3.0
2.9
nmol/l
0.9
0.8
0.52
33
250
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
38
294
1.28
0.74
1.3
1.1
mg/l
29.6
44.3
1.41
30
235
(3014051) Protein [Presence] in Urine by Test strip
85
717
1.17
0.74
2.3
2.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
35
268
1.29
0.73
1.4
1.4
titre
70.0
209.5
—
9
63
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
38
1.82
0.73
1.7
1.9
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
75
627
1.19
0.73
1.1
1.1
u/ml
6.7
6.9
0.04
38
293
(3014133) Dog dander IgE Ab [Units/volume] in Serum
81
682
1.18
0.72
1.1
1.1
u/ml
4.9
5.2
0.04
38
302
(3045683) HLA typing for celiac disease panel - Blood or Tissue
31
234
1.31
0.72
1.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
188
1678
1.11
0.72
2.0
1.8
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
66
546
1.20
0.72
1.0
1.1
u/ml
0.1
0.3
0.66
21
147
(3028433) Virus identified in Specimen by Culture
14
91
1.52
0.72
1.1
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
13
83
1.55
0.71
1.3
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
13
83
1.55
0.71
1.3
1.9
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
33
252
1.30
0.71
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
33
252
1.30
0.71
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
43
340
1.25
0.71
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
39
305
1.27
0.71
1.6
1.7
—
—
—
0
0
(4027681)
31
235
1.31
0.70
1.3
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
41
1.69
0.69
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
84
1.53
0.68
2.9
2.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
26
193
1.33
0.68
1.3
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
23
168
1.35
0.67
3.0
2.2
ml
487.4
579.9
0.40
14
117
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
21
151
1.38
0.67
1.9
1.7
u/field
1.6
3.7
0.71
15
107
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
70
812
0.85
0.67
1.1
1.2
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
7
43
1.61
0.66
1.9
1.8
pmol/l
15.1
25.5
—
7
36
(3023383) Lactate [Moles/volume] in Pleural fluid
7
43
1.61
0.66
1.6
1.3
mmol/l
2.9
3.1
—
7
35
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
13
85
1.51
0.66
1.3
1.9
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
25
186
1.33
0.65
4.8
5.0
mg/l
7.3
8.3
0.44
20
153
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
28
1.77
0.65
1.4
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
81
690
1.16
0.65
1.5
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
35
274
1.26
0.64
1.0
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
53
435
1.21
0.64
1.2
1.1
%
115.6
115.8
0.01
48
395
(4211845)
22
161
1.35
0.64
2.8
2.8
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
19
136
1.38
0.63
1.5
1.9
ug/min
194.2
69.5
—
6
33
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
16
111
1.43
0.62
1.1
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
99
860
1.14
0.62
2.6
3.6
u/ml
287.9
588.7
0.52
74
720
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
15
103
1.44
0.61
1.1
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.60
0.0
2.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
74
631
1.16
0.60
1.2
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
8
51
1.55
0.59
1.3
2.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
57
477
1.18
0.58
1.4
1.5
mmol/l
7.2
6.9
0.30
41
328
(4035726)
272
2505
1.08
0.57
1.4
1.4
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
35
1.70
0.57
1.0
1.2
—
—
—
0
0
(4024509)
37
297
1.23
0.57
1.7
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
15
105
1.41
0.57
2.5
2.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
26
200
1.29
0.56
8.0
3.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
6
36
1.65
0.56
1.3
2.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
67
571
1.16
0.56
1.1
1.1
u/ml
4.5
4.0
0.05
20
246
(40768806) Pleura Pathology biopsy report
23
175
1.30
0.54
1.5
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
73
1.49
0.53
1.8
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
45
528
0.84
0.53
1.7
1.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
39
1.52
0.52
1.3
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
39
1.52
0.52
1.2
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
39
1.52
0.52
1.0
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
20
150
1.32
0.52
1.3
2.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
20
150
1.32
0.52
1.3
2.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
161
1459
1.09
0.51
1.6
1.8
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
74
1.47
0.51
1.2
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
74
1.47
0.51
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
13
91
1.41
0.50
1.4
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
29
231
1.24
0.49
1.0
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
31
250
1.23
0.48
4.5
3.4
%
57.7
55.8
0.17
15
171
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
73
637
1.13
0.47
1.4
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
83
731
1.12
0.46
1.4
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
41
342
1.19
0.46
1.7
1.5
mosm/kgh2o
279.5
283.6
0.77
35
263
(3022670) pH of Venous cord blood
7
48
1.44
0.46
1.0
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
119
0.66
0.45
2.3
2.5
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
119
0.66
0.45
4.5
5.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
7
49
1.41
0.45
1.7
2.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
37
433
0.84
0.44
1.4
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
34
280
1.20
0.44
1.1
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
455
4304
1.05
0.44
1.8
1.6
%
1.5
1.4
3.23
410
3878
(40765089) Chromosome analysis panel - Blood by G-banded
26
208
1.24
0.44
1.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
37
308
1.19
0.43
7.0
2.9
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
125
1347
0.91
0.43
1.5
1.5
mg/l
5.6
3.2
1.03
85
883
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
31
1.59
0.42
1.2
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
31
1.59
0.42
1.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
56
1.41
0.42
6.6
6.7
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
15
0.00
0.41
0.0
1.1
—
33.2
—
0
15
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
58
1.36
0.41
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
325
3057
1.05
0.40
3.2
3.0
ug/l
0.8
0.8
0.12
224
2030
(3044927) Protein electrophoresis panel - Urine
27
220
1.21
0.40
1.1
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
34
1.45
0.40
1.2
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
48
413
1.15
0.39
1.4
1.2
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
10
70
1.41
0.39
1.3
1.6
nmol/l
22.0
14.8
—
5
21
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
97
873
1.10
0.39
1.4
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
173
1828
0.93
0.38
1.5
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
9
65
1.37
0.38
1.2
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
36
304
1.17
0.37
1.4
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
71
1.39
0.37
1.3
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
80
1.36
0.36
1.1
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
42
361
1.15
0.36
1.5
1.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
42
1.41
0.35
1.0
1.0
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
28
233
1.19
0.35
1.0
1.0
mu/l
6.3
9.2
2.25
19
196
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
32
270
1.17
0.34
1.5
2.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
97
881
1.09
0.34
1.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
260
2447
1.05
0.34
2.6
2.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
51
566
0.89
0.33
1.2
1.1
iu/ml
71.7
889.9
0.57
12
169
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
15
117
1.27
0.32
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
629
6042
1.03
0.32
1.8
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
20
238
0.83
0.31
1.5
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
13
100
1.29
0.31
2.1
2.4
ph
7.4
7.4
—
5
32
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
31
264
1.16
0.31
1.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
16
127
1.25
0.31
1.1
1.6
—
7.6
—
0
9
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
59
645
0.90
0.31
2.9
2.0
nmol/l
0.8
0.7
0.78
51
541
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
26
219
1.17
0.29
1.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
202
0.83
0.27
1.3
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
64
1.24
0.27
1.1
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
8
64
1.24
0.27
1.1
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
25
212
1.17
0.27
2.7
2.8
—
27.7
—
0
6
(3033799) Differential panel - Peritoneal fluid
8
65
1.22
0.26
1.3
1.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
65
1.22
0.26
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
16
130
1.22
0.26
1.5
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
130
1214
1.06
0.25
1.6
1.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
22
186
1.17
0.25
1.1
1.1
u/l
1.0
1.1
—
9
80
(3016038) Potassium [Moles/volume] in Urine
22
186
1.17
0.25
1.6
1.8
mmol/l
32.1
34.4
0.30
22
169
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
11
86
1.26
0.24
1.2
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
37
1.34
0.23
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
37
328
1.12
0.23
1.2
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
45
488
0.91
0.22
1.2
1.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
16
133
1.19
0.22
1.0
1.0
u/ml
7.5
18.3
—
5
18
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
35
311
1.11
0.21
1.1
1.1
%
96.2
94.9
0.11
30
296
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
533
5150
1.03
0.21
1.5
1.5
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
11
0.00
0.21
0.0
1.1
—
8.2
—
0
11
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
12
0.00
0.21
0.0
1.0
—
164.3
—
0
7
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013762) Body weight Measured
0
13
0.00
0.20
0.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
79
1.25
0.20
1.1
1.4
ug/l
5.6
9.4
—
10
79
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
25
218
1.13
0.20
1.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
47
1.26
0.20
1.0
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
6
47
1.26
0.20
1.0
1.2
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
14
0.00
0.20
0.0
1.2
—
71.9
—
0
14
(3035933) Granulocytes/100 leukocytes in Blood
15
174
0.85
0.20
1.7
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
26
228
1.13
0.20
1.1
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
25
219
1.13
0.19
1.8
2.1
u/field
1.8
2.6
0.71
15
91
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
219
1.13
0.19
1.2
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
22
191
1.14
0.19
1.2
1.1
miu/ml
1486.5
1441.6
0.05
22
191
(3000764) Benzodiazepines [Presence] in Urine
276
2647
1.03
0.19
2.5
2.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
11
89
1.22
0.19
1.5
1.8
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
52
1.14
0.19
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
52
1.14
0.19
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
52
1.14
0.19
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
52
1.14
0.19
1.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
80
1.24
0.18
1.8
2.9
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
36
324
1.10
0.18
1.5
1.4
mmol/l
11.3
11.9
—
5
60
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
58
1.19
0.18
1.1
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
278
2671
1.03
0.18
2.5
1.9
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
18
155
1.15
0.17
2.1
1.9
nmol/l
0.1
0.1
0.16
12
110
(3048879) Bone marrow aspiration report
8
67
1.18
0.16
1.1
2.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
67
1.18
0.16
2.1
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
278
2676
1.03
0.16
2.5
2.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
69
1.15
0.16
1.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
69
1.15
0.16
1.0
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
69
1.15
0.16
1.0
1.2
—
—
—
0
0
(4133840)
8
71
1.11
0.16
1.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
9
78
1.14
0.15
1.7
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
24
262
0.90
0.15
1.2
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
39
358
1.08
0.14
4.0
3.6
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
184
1766
1.03
0.14
2.4
3.2
u/ml
71.9
56.0
0.28
178
1700
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
29
263
1.09
0.13
1.5
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
52
484
1.06
0.13
1.1
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
34
312
1.08
0.12
2.0
1.9
mg/l
26.7
25.1
0.06
11
85
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
14
156
0.89
0.12
1.1
1.3
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
16
141
1.12
0.12
1.3
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
12
135
0.88
0.11
1.0
1.1
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
17
186
0.90
0.11
1.0
1.0
kpa
3.0
3.3
0.33
11
157
(3044242) Glucose [Moles/volume] in Arterial blood
10
114
0.87
0.11
1.8
1.9
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
18
161
1.11
0.11
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
317
3185
0.98
0.10
1.5
1.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
45
1.10
0.09
2.0
1.5
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
46
1.07
0.09
1.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
14
124
1.12
0.09
1.6
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
385
3755
1.01
0.09
1.3
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
61
0.81
0.08
3.0
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
61
0.81
0.08
3.0
2.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
206
2072
0.98
0.08
1.5
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
10
87
1.14
0.08
1.4
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
110
1060
1.03
0.08
1.7
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
33
309
1.06
0.08
1.6
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
68
1.02
0.07
2.6
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
68
1.02
0.07
3.3
1.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
110
0.90
0.06
2.7
2.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
19
176
1.07
0.05
1.2
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
68
656
1.02
0.05
1.0
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
21
219
0.95
0.05
1.4
1.8
mmol/l
6.7
6.1
—
10
168
(21491868) Cryoglobulin [Mass/volume] in Serum
10
90
1.10
0.04
1.2
1.1
—
0.1
—
0
5
(3004959) Base excess in Arterial cord blood by calculation
18
188
0.95
0.04
1.0
1.0
mmol/l
-3.1
-3.2
—
7
44
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
18
188
0.95
0.04
1.0
1.0
kpa
7.2
7.4
0.06
11
159
(3006598) pH of Arterial cord blood
18
188
0.95
0.04
1.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
68
658
1.02
0.04
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
268
2628
1.01
0.03
2.2
2.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
10
91
1.09
0.03
1.4
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
91
1.09
0.03
2.3
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
19
179
1.05
0.03
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
354
3481
1.01
0.02
4.5
3.9
%
32.9
32.8
0.05
236
2322
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
82
799
1.01
0.02
1.4
1.4
ug/l
4.2
5.2
0.78
77
741
(3033705) Calcium.ionized [Moles/volume] in Venous blood
21
216
0.96
0.02
2.6
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
124
1236
0.99
0.02
1.5
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
77
752
1.01
0.01
1.3
1.3
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
25
254
0.97
0.01
1.1
1.1
mg/l
292.9
291.3
0.03
17
231
(3000330) Specific gravity of Urine by Test strip
138
1372
0.99
0.01
3.0
2.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
18
174
1.02
0.00
1.3
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
14
140
0.99
0.00
1.1
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
22
219
0.99
0.00
1.5
2.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
23
227
1.00
0.00
4.0
3.0
mg/l
112.6
31.7
0.62
17
169
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.6
—
0.1
—
0
5
(3040794) Aluminum [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
8
84
0.94
0.00
1.0
1.0
g/l
158.4
163.3
—
8
84
(44806420)
5
54
0.91
0.00
2.4
2.3
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
7
72
0.96
0.00
1.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
90
0.99
0.00
1.4
1.8
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
2.6
—
0
8
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
49
1.01
0.00
1.2
1.4
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
63
0.94
0.00
1.0
1.1
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
83
0.95
0.00
1.0
1.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
57
0.87
0.00
1.2
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
59
1.01
0.00
1.7
2.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
6
66
0.90
0.00
1.2
1.3
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
5
52
0.95
0.00
1.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
67
0.88
0.00
1.2
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_CARDIAC_MURMU_OTHER_CARDIAC_SOUNDS – Cardiac murmurs and other cardiac sounds
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).